Ethinylestradiol(30μg)-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?

BACKGROUND: We are hereby investigating for the first time the effect of the association ethinylestradiol(30μg)-drospirenone (3mg) (DRP/EE(30μg)) plus metformin and weight loss on endothelial status and C-reactive protein (hsCRP) levels in polycystic ovary syndrome (PCOS). METHODS: 25 young women wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilie, Ioana Rada, Marian, Ioan, Mocan, Teodora, Ilie, Razvan, Mocan, Lucian, Duncea, Ileana, Pepene, Carmen Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413550/
https://www.ncbi.nlm.nih.gov/pubmed/22713099
http://dx.doi.org/10.1186/1472-6823-12-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413550/
https://www.ncbi.nlm.nih.gov/pubmed/22713099
http://dx.doi.org/10.1186/1472-6823-12-9

Ejemplares similares